Early Access

10-KPeriod: FY2024

HCA Healthcare, Inc. Annual Report, Year Ended Dec 31, 2024

Filed February 14, 2025For Securities:HCA

Summary

HCA Healthcare, Inc. reported a robust financial performance for the fiscal year 2024, with revenues reaching $70.6 billion, an increase of 8.7% year-over-year. This growth was driven by a combination of increased patient volumes, as evidenced by a 5.3% rise in equivalent admissions, and a 3.2% increase in revenue per equivalent admission. Net income attributable to HCA Healthcare, Inc. was $5.76 billion, or $22.00 per diluted share, a notable increase from the prior year. The company continued to expand its footprint, operating 190 hospitals and 124 ambulatory surgery centers by year-end. Management highlights strategic investments in clinical systems, digital capabilities, and workforce development as key drivers for sustained growth and operational excellence. Despite strong financial results, HCA faces several risks including significant indebtedness (totaling $43.031 billion), potential labor shortages and associated cost increases, cybersecurity threats, and regulatory changes in the healthcare industry. The company's geographic concentration in Florida and Texas also exposes it to specific regional risks. Management is focused on a disciplined development strategy, enhancing clinical and operational performance, and aligning with value-based care initiatives while navigating these challenges.

Financial Statements
Beta
Revenue$70.60B
Operating Expenses$62.08B
Interest Expense$2.06B
Net Income$5.76B
EPS (Basic)$22.27
EPS (Diluted)$22.00
Shares Outstanding (Basic)258.60M
Shares Outstanding (Diluted)261.81M

Key Highlights

  • 1HCA Healthcare achieved significant revenue growth, reaching $70.6 billion in 2024, an increase of 8.7% compared to 2023, driven by higher patient volumes and revenue per admission.
  • 2Net income attributable to HCA Healthcare, Inc. increased to $5.76 billion ($22.00 per diluted share) in 2024, up from $5.24 billion ($18.97 per diluted share) in 2023.
  • 3The company operated 190 hospitals and 124 ambulatory surgery centers as of December 31, 2024, reflecting continued expansion and network development.
  • 4Consolidated admissions grew by 5.0% in 2024, with same-facility admissions increasing by 4.9%, indicating steady demand for services.
  • 5The company repurchased approximately 17.8 million shares of its common stock in 2024, demonstrating a commitment to returning capital to shareholders.
  • 6Despite strong performance, HCA has substantial indebtedness of $43.031 billion as of December 31, 2024, posing potential financial risks.
  • 7Operational challenges include potential labor shortages and rising costs for healthcare professionals, which management is actively addressing through various initiatives.

Frequently Asked Questions